Expression of Bile Duct Transcription Factor HNF1β Predicts Early Tumor Recurrence and Is a Stage-Independent Prognostic Factor in Hepatocellular Carcinoma

HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes

(2013) Y.L. Hu et al.   GENETICS AND MOLECULAR RESEARCH

S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors

(2013) Ray-Hwang Yuan et al.   PLoS One

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

(2013) Hui Shen et al.   Nature Communications

Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the milan criteria in transplantable hepatocellular carcinoma: A retrospective analysis based on tissue microarrays

(2012) Ju Hyun Shim et al.   LIVER TRANSPLANTATION

Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers

(2012) Jung Il Lee   WORLD JOURNAL OF GASTROENTEROLOGY

Hepatocellular Carcinoma Expressing Cholangiocyte Phenotype Is a Novel Subtype with Highly Aggressive Behavior

(2011) Xin-Yuan Lu et al.   ANNALS OF SURGICAL ONCOLOGY

Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma

(2010) Ray-Hwang Yuan et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies

(2010) Katherine S. Elliott et al.   PLoS One

Downregulation of HNF-1B in Renal Cell Carcinoma Is Associated With Tumor Progression and Poor Prognosis

(2010) Alexander Buchner et al.   UROLOGY

Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection

(2008) X.-R. Yang et al.   CLINICAL CANCER RESEARCH